Centene (CNC) Set to Announce Earnings on Tuesday

Centene (NYSE:CNCGet Rating) will release its earnings data before the market opens on Tuesday, April 26th. Analysts expect Centene to post earnings of $1.68 per share for the quarter. Centene has set its FY 2022 guidance at $5.300-$5.500 EPS and its FY22 guidance at $5.30-$5.50 EPS.Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Centene (NYSE:CNCGet Rating) last posted its quarterly earnings data on Tuesday, February 8th. The company reported $1.01 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.98 by $0.03. Centene had a return on equity of 11.47% and a net margin of 1.07%. The firm had revenue of $32.57 billion during the quarter, compared to analyst estimates of $32.52 billion. During the same period last year, the company posted $0.46 EPS. The business’s quarterly revenue was up 15.1% on a year-over-year basis. On average, analysts expect Centene to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

CNC stock opened at $84.88 on Tuesday. The stock has a 50-day moving average price of $84.77 and a 200-day moving average price of $78.57. Centene has a 1-year low of $59.33 and a 1-year high of $89.79. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.69. The firm has a market cap of $49.47 billion, a PE ratio of 37.39, a price-to-earnings-growth ratio of 1.25 and a beta of 0.52.

In other news, EVP Mark J. Brooks sold 2,774 shares of the business’s stock in a transaction that occurred on Thursday, January 20th. The stock was sold at an average price of $80.00, for a total value of $221,920.00. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Mark J. Brooks sold 3,690 shares of the business’s stock in a transaction that occurred on Thursday, March 24th. The stock was sold at an average price of $82.71, for a total value of $305,199.90. The disclosure for this sale can be found here. 1.50% of the stock is owned by insiders.

Institutional investors have recently bought and sold shares of the stock. EverSource Wealth Advisors LLC purchased a new position in Centene in the fourth quarter valued at approximately $26,000. Zullo Investment Group Inc. purchased a new position in Centene in the fourth quarter valued at approximately $34,000. Flagship Harbor Advisors LLC bought a new stake in Centene during the 4th quarter valued at $209,000. Penserra Capital Management LLC raised its holdings in Centene by 19.8% during the 4th quarter. Penserra Capital Management LLC now owns 3,042 shares of the company’s stock valued at $250,000 after acquiring an additional 502 shares during the period. Finally, SkyView Investment Advisors LLC bought a new stake in Centene during the 4th quarter valued at $196,000. Institutional investors and hedge funds own 90.47% of the company’s stock.

Several research firms have recently weighed in on CNC. Truist Financial lifted their price objective on Centene from $94.00 to $96.00 and gave the stock a “buy” rating in a research report on Wednesday, January 5th. Mizuho boosted their target price on Centene from $78.00 to $84.00 and gave the company a “neutral” rating in a research report on Wednesday, February 9th. StockNews.com assumed coverage on Centene in a research report on Thursday, March 31st. They issued a “strong-buy” rating for the company. Sanford C. Bernstein boosted their target price on Centene from $94.00 to $108.00 in a research report on Tuesday, January 11th. Finally, Barclays assumed coverage on Centene in a research report on Friday, January 7th. They issued an “overweight” rating and a $95.00 target price for the company. Four research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $91.61.

About Centene (Get Rating)

Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs.

Featured Articles

Earnings History for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.